Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 12 - Designing Nanodelivery Systems for In Vivo Use

  • James F. Leary, Purdue University, Indiana
  • Book:
    Fundamentals of Nanomedicine
    Published online:
    08 March 2022
    Print publication:
    31 March 2022, pp 232-254

  • Summary

    The normal paradigm for developing a new nanomedical system is to start with an in vitro cell line (usually human) system and then progress to excised, or biopsied , tissue from a human (ex vivo). Finally, to better simulate the effects of a total organism, we begin in vivo studies, usually on an animal system. This has been the general paradigm for decades. Now we have new “organ-on-a-chip” in vitro models that generate organ-like human tissue on an in vitro format. There have even been more recent promising efforts at generating “human-on-a-chip” technologies.